TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
ORMP

Oramed Pharmaceuticals Inc

Healthcare · Biotechnology

4.70$ -0.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Oramed Pharmaceuticals Inc (ORMP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 370 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ORMP
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
231 221 204 184 165 155 148 162 220 231 269 370
176 163 177 153 143 143 131 99 136 133 68 53
5.5 9.1 19 85 42 54 75 16 52 46 13 15
175 162 177 153 142 142 131 98 135 126 66 51
– – – – – – – – – 4.6 – 0.6
83 58 38 8.1 9.6 9.9 7.6 8.1 18 31 31 52
78 53 34 3.7 5.3 5.7 5.5 3.7 6.1 19 11 11
76 51 32 0.3 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.2
2.6 0.6 1.3 3.5 5.0 0.8 0.5 0.7 0.6 0.4 0.5 0.4
149 164 167 177 156 146 141 155 203 200 238 317
-171 -158 -156 -147 -166 -177 -184 -171 -123 -123 -85 -7.0
40 40 42 42 41 40 41 43 43 40 42 43

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?